Common anti-inflammatory drugs are potentially therapeutic for Parkinson's disease?

被引：29

作者：

Asanuma, Masato ^{[1
]}

Miyazaki, Ikuko ^{[1
]}

机构：

[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Brain Sci, Okayama 7008558, Japan

来源：

EXPERIMENTAL NEUROLOGY | 2007年 / 206卷 / 02期

关键词：

D O I：

10.1016/j.expneurol.2007.05.006

中图分类号：

Q189 [神经科学];

学科分类号：

071006 [神经生物学];

摘要：

引用

收藏

页码：172 / 178

页数：7

相关论文

共 72 条

[1]

NONSTEROIDAL ANTIINFLAMMATORY DRUGS INHIBIT EXPRESSION OF THE INDUCIBLE NITRIC-OXIDE SYNTHASE GENE [J].

AEBERHARD, EE ;

HENDERSON, SA ;

ARABOLOS, NS ;

GRISCAVAGE, JM ;

CASTRO, FE ;

BARRETT, CT ;

IGNARRO, LJ .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 208 (03) :1053-1059

[2]

ARIMOTO T, 2007, AGING, V28, P894

[3]

Asanuma M, 2004, ACTA MED OKAYAMA, V58, P221

[4]

Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals [J].

Asanuma, M ;

Nishibayashi-Asanuma, S ;

Miyazaki, I ;

Kohno, M ;

Ogawa, N .

JOURNAL OF NEUROCHEMISTRY, 2001, 76 (06) :1895-1904

[5]

Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation [J].

Asanuma, Masato ;

Miyazaki, Ikuko .

EXPERT REVIEW OF NEUROTHERAPEUTICS, 2006, 6 (09) :1313-1325

[6]

Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice [J].

Aubin, N ;

Curet, O ;

Deffois, A ;

Carter, C .

JOURNAL OF NEUROCHEMISTRY, 1998, 71 (04) :1635-1642

[7]

Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implications for Parkinson's disease [J].

Berman, SB ;

Hastings, TG .

JOURNAL OF NEUROCHEMISTRY, 1999, 73 (03) :1127-1137

[8]

Role of the peroxisome proliferator-activated receptor-γ (PPAR-γ) and its natural ligand 15-deoxy-Δ12,14-prostaglandin J2 in the regulation of microglial functions [J].

Bernardo, A ;

Levi, G ;

Minghetti, L .

EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (07) :2215-2223

[9]

Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: A case-control study [J].

Bower, J. H. ;

Maraganore, D. M. ;

Peterson, B. J. ;

Ahlskog, J. E. ;

Rocca, W. A. .

NEUROLOGY, 2006, 67 (03) :494-496

[10]

Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease [J].

Breidert, T ;

Callebert, J ;

Heneka, MT ;

Landreth, G ;

Launay, JM ;

Hirsch, EC .

JOURNAL OF NEUROCHEMISTRY, 2002, 82 (03) :615-624

← 1 2 3 4 5 6 7 8 →